27J-11280-01195
4 vaccinations
1 coded response
42 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-25
- 2020-12-30
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-15
- 2021-01-22
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-04-07
- 2021-07-07
-
2021-09-28
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-28
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Breast pain — Feeling: Good · Site: PainFree text: Pain in the armpit/breast areaMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-05
- 2021-10-12
- 2021-10-26
- 2021-11-02
- 2021-11-09
- 2021-12-28
- 2022-03-29
-
2022-09-14
Dose 4 — Moderna
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-12-14
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-14 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-07 | priority 2/3 |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in the armpit/breast area
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | · | · | ✓ |
| SRO | Breast pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release